CD34


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
13 01 2021
Historique:
received: 27 10 2020
accepted: 02 11 2020
pubmed: 13 11 2020
medline: 16 3 2021
entrez: 12 11 2020
Statut: epublish

Résumé

In human cytomegalovirus (HCMV)-seropositive patients, CD34

Identifiants

pubmed: 33177198
pii: JVI.02105-20
doi: 10.1128/JVI.02105-20
pmc: PMC7925096
pii:
doi:

Substances chimiques

Antigens, CD34 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI127335
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM134974
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI056077
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI021640
Pays : United States

Informations de copyright

Copyright © 2021 American Society for Microbiology.

Références

J Immunol Methods. 2009 Aug 15;347(1-2):70-8
pubmed: 19567251
Hum Immunol. 2009 Oct;70(10):790-802
pubmed: 19524633
Stem Cells. 2012 Jan;30(1):33-41
pubmed: 22213481
Science. 1998 Nov 6;282(5391):1145-7
pubmed: 9804556
Front Microbiol. 2019 Oct 09;10:2233
pubmed: 31649625
Stem Cells. 2012 Jan;30(1):10-4
pubmed: 22102565
J Immunol. 2008 Jul 1;181(1):698-711
pubmed: 18566437
Methods Mol Biol. 2013;997:23-33
pubmed: 23546745
Sci Rep. 2017 Apr 20;7(1):937
pubmed: 28428537
J Virol. 2012 Sep;86(18):9854-65
pubmed: 22761372
Cell Stem Cell. 2009 Jul 2;5(1):111-23
pubmed: 19570518
Nature. 2019 Oct;574(7778):365-371
pubmed: 31597962
mBio. 2018 Apr 24;9(2):
pubmed: 29691342
Stem Cell Rev Rep. 2020 Feb;16(1):3-32
pubmed: 31760627
Viruses. 2018 Aug 20;10(8):
pubmed: 30127257
Annu Rev Virol. 2016 Sep 29;3(1):333-357
pubmed: 27501258
Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69
pubmed: 21236396
J Virol. 1991 Dec;65(12):6581-8
pubmed: 1658363
Virol J. 2016 Oct 22;13(1):179
pubmed: 27770817
Nat Cell Biol. 2017 Apr;19(4):271-281
pubmed: 28319093
Blood. 2005 Jan 15;105(2):617-26
pubmed: 15374881
J Virol. 2004 May;78(9):4444-53
pubmed: 15078925
PLoS Pathog. 2013;9(5):e1003366
pubmed: 23717203
Curr Top Microbiol Immunol. 2008;325:297-313
pubmed: 18637513
Methods Mol Biol. 2014;1119:99-112
pubmed: 24639220
J Virol. 1999 Jun;73(6):4806-12
pubmed: 10233941
Hematology Am Soc Hematol Educ Program. 2007;:11-6
pubmed: 18024603
Virology. 2014 Jan 5;448:125-32
pubmed: 24314643
Ann Hematol. 1992 Jun;64 Suppl:A128-31
pubmed: 1322182
mBio. 2013 May 28;4(3):e00298-13
pubmed: 23716573
J Virol. 1986 May;58(2):434-40
pubmed: 3009858
Nat Cell Biol. 2018 May;20(5):610-619
pubmed: 29662178
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16255-60
pubmed: 12456880
J Virol. 2001 Aug;75(16):7543-54
pubmed: 11462026
Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):E10586-E10595
pubmed: 29158406
Exp Hematol. 1999 Sep;27(9):1418-27
pubmed: 10480433
Cell Host Microbe. 2020 Jan 8;27(1):104-114.e4
pubmed: 31866424
mBio. 2018 Mar 13;9(2):
pubmed: 29535194
Nat Protoc. 2011 Mar;6(3):296-313
pubmed: 21372811
Cell Stem Cell. 2007 Dec 13;1(6):635-45
pubmed: 18371405
Stem Cell Reports. 2015 Feb 10;4(2):282-96
pubmed: 25680479
Blood. 2004 Aug 1;104(3):687-95
pubmed: 15090458
mBio. 2019 Aug 20;10(4):
pubmed: 31431555
J Leukoc Biol. 2012 Oct;92(4):743-52
pubmed: 22715139
J Virol. 2012 Oct;86(19):10714-23
pubmed: 22837201
J Gen Virol. 1996 Dec;77 ( Pt 12):3099-102
pubmed: 9000102
Blood. 2007 Aug 1;110(3):937-45
pubmed: 17440050
Nature. 2017 May 25;545(7655):432-438
pubmed: 28514439
J Gen Virol. 2010 Mar;91(Pt 3):599-604
pubmed: 19906945
J Biol Chem. 2019 Aug 30;294(35):12901-12910
pubmed: 31273084
Mol Cells. 1999 Feb 28;9(1):37-44
pubmed: 10102569
J Virol. 2013 Sep;87(17):9802-12
pubmed: 23824798

Auteurs

Lindsey B Crawford (LB)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.

Meaghan H Hancock (MH)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.

Hillary M Struthers (HM)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.

Daniel N Streblow (DN)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.

Andrew D Yurochko (AD)

Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.

Patrizia Caposio (P)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.

Felicia D Goodrum (FD)

Department of Immunobiology, BIO5 Institute, University of Arizona, Tucson, Arizona, USA.

Jay A Nelson (JA)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA nelsonj@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH